Clin2
NCT07657390Possibly a fitRecruiting

Acupoint plaster for moderate to severe cancer pain

Cancer Pains

Part of Pain clinical trials.

This study tests a special pain-relief plaster placed on acupoints (body points used in acupuncture) to see if it can help people with moderate to severe cancer pain who are already taking pain medications. The goal is to find a gentler way to improve pain control.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
198 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have moderate to severe cancer pain (rated 4 to 8 on a 0–10 pain scale).
  • You are 18 years or older.
  • You need daily pain medications and expect to need them for at least 2 more weeks.
  • Your doctor says your overall health is fair (ECOG score 0–3, meaning you are up and about at least half the day).
  • You are not allergic to opioids or the ingredients in the study plaster.
  • You are not currently in the middle of chemotherapy (a short break is okay).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07447856Recruiting· Phase 1
Herbal plasters for pain relief while using opioids

This trial tests a topical herbal plaster to see if it can help reduce pain in people with cancer who are already taking opioids. The plaster is placed on the most painful area and may allow you to use less opioid medication.

Basking Ridge, New Jersey
NCT07489625Recruiting· Early Phase 1
Electroacupuncture and ear acupressure for cancer pain

This study tests whether adding electroacupuncture (a treatment using mild electric pulses on needles) and ear acupressure (pressing on specific points on the ear) to the pain medicine hydromorphone helps reduce cancer-related pain that isn't well managed by usual treatments.

Xining
NCT05265052Not yet recruiting· Phase 2
Test new cancer pain medicine with extended-release oxycodone

This Phase 2 study tests a new medicine (3D1002) taken together with extended-release oxycodone to improve moderate to severe cancer pain. You may be considered if your cancer pain is stable and you can follow the study’s strict pain-medication rules.

NCT05850130Recruiting
Acupuncture to treat nerve pain from oxaliplatin chemotherapy

This study tests whether acupuncture can reduce nerve pain caused by oxaliplatin chemotherapy in people with gastrointestinal cancers. It may help lessen symptoms like tingling, numbness, or burning that affect hands or feet.

Créteil
NCT06814977Recruiting
Acupuncture for joint pain in cancer survivors

This study tests whether acupuncture can help reduce joint pain in cancer survivors. If you have bothersome joint pain that has lasted at least a month, acupuncture might offer relief.

New York, New York
NCT06778954Recruiting
Pain control gel after stomach cancer surgery

This trial tests a gel (ropivacaine in a special polymer) applied during stomach cancer surgery to reduce pain after the operation. The goal is to help patients recover with less pain and fewer side effects from painkillers.

Seoul

Hear when a new Cancer Pains trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.